Medical devices, healthcare technology and the business of care
510(k) clearance · K262068

Khelix Magnetic Sensor Electrophysiology Catheter (SS1-*-*-MAG)

CathRx, Ltd. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK262068

What did the FDA decide?

CathRx, Ltd. received a substantially equivalent (SESE) decision for the Khelix Magnetic Sensor Electrophysiology Catheter (SS1-*-*-MAG) under 510(k) number K262068. FDA recorded the decision on 2026-10-09, with the application received 06/22/2026. The device falls under product code DRF, regulation 870.1220, in the Cardiovascular specialty and review panel, and was handled as a Traditional 510(k) not reviewed by a third party. SESE means the device was cleared for marketing as substantially equivalent to a predicate; it is not a PMA approval.

The record identifies the applicant as CathRx, Ltd. of Rydalmere, Australia, with Acorn N Oakes, LLC listed as correspondent. The submission was not a combination product, and no predetermined change control plan was authorized. The public record does not state the predicate device, the specific magnetic sensor design or component changes, or any indications for use, so those details remain unknown from this source. No clinical or performance conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 9, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262068
Regulatory pathway
510(k) premarket notification
Applicant
CathRx, Ltd.
Product code
DRF
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Electrode Recording, Or Probe, Electrode Recording.

Applicant
CathRx, Ltd.
Product code
DRF
FDA device class
2

FDA decision timeline

  1. K262068 received

    Application receipt date recorded by FDA.

  2. K262068 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DRF

Product / regulatory recordCompanyPathwayDecision dateSource
Imricor Medical Systems, Inc.510(k) clearanceJan 8, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

CathRx, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Rydalmere

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records